JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Journal of Endocrinology (2006) 191, 707-714       DOI: 10.1677/joe.1.07056
© 2006 Society for Endocrinology
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boelen, A
Right arrow Articles by Fliers, E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boelen, A
Right arrow Articles by Fliers, E

Chronic local inflammation in mice results in decreased TRH and type 3 deiodinase mRNA expression in the hypothalamic paraventricular nucleus independently of diminished food intake

A Boelen, J Kwakkel, W M Wiersinga and E Fliers

Department of Endocrinology and Metabolism, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

(Requests for offprints should be addressed to A Boelen; Email: a.boelen{at}amc.uva.nl)


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
During illness, changes in thyroid hormone metabolism occur, known as nonthyroidal illness and characterised by decreased serum triiodothyronine (T3) and thyroxine (T4) without an increase in TSH. A mouse model of chronic illness is local inflammation, induced by a turpentine injection in each hind limb. Although serum T3 and T4 are markedly decreased in this model, it is unknown whether turpentine administration affects the central part of the hypothalamus–pituitary–thyroid axis (HPT-axis). We therefore studied thyroid hormone metabolism in hypothalamus and pituitary of mice during chronic inflammation induced by turpentine injection. Using pair-fed controls, we could differentiate between the effects of chronic inflammation per se and the effects of restricted food intake as a result of illness. Chronic inflammation increased interleukin (IL)-1ß mRNA expression in the hypothalamus more rapidly than in the pituitary. This hypothalamic cytokine response was associated with a rapid increase in local D2 mRNA expression. By contrast, no changes were present in pituitary D2 expression. TSHß mRNA expression was altered compared with controls. Comparing chronic inflamed mice with pair-fed controls, both preproTSH releasing hormone (TRH) and D3 mRNA expression in the paraventricular nucleus were significantly lower 48 h after turpentine administration. The timecourse of TSHß mRNA expression was completely different in inflamed mice compared with pair-fed mice. Turpentine administration resulted in significantly decreased TSHß mRNA expression only after 24 h while later in time it was lower in pair-fed controls. In conclusion, central thyroid hormone metabolism is altered during chronic inflammation and this cannot solely be attributed to diminished food intake.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
Acute systemic illness induced by bacterial endotoxin (lipopoly saccharide; LPS) administration, results in altered peripheral and central thyroid hormone metabolism, so-called nonthyroidal illness (NTI; Papanicolaou 2000, Koenig 2005). Pituitary D2 and TRß mRNA expression decrease while hypothalamic D2 mRNA expression (Boelen et al. 2004) and activity (Fekete et al. 2004) increase shortly after LPS administration. The D2 increase is associated with increased hypothalamic interleukin (IL)-1ß mRNA expression (Boelen et al. 2004). It is known that chronic inflammation in mice, induced by an s.c. injection of turpentine in each hind limb also results in altered peripheral thyroid hormone metabolism (Chopra et al. 1987, Woloski & Jamieson 1987) and we have shown recently that besides decreased serum triiodothyronine (T3) and thyroxine (T4) levels liver type 1 deiodinase (D1) did not change and type 3 deiodinase (D3) activity increased in inflammatory cells at the site of inflammation (Boelen et al. 2005).

The observed decrease in serum thyroid hormone levels during chronic inflammation might be due in part to diminished food intake during the first days of illness. It is known that in rats starvation results in decreased serum thyroid hormones and thyroid-stimulating hormone (TSH) concentrations and decreased TSH releasing hormone (TRH) mRNA expression in the hypothalamic paraventricular nucleus (PVN) associated with a modest increase in hypothalamic D2 activity (Diano et al. 1998). These alterations are partly regulated by leptin which is downregulated during starvation (Ahima et al. 1996, Legradi et al. 1997, Coppola et al. 2005). The observed modest increase in D2 activity during starvation is in contrast with the rapid, cytokine-related, more than a threefold increase in D2 activity (Fekete et al. 2004) and mRNA expression (Boelen et al. 2004) observed shortly after LPS administration. Faggioni et al.(1998) showed that both LPS and turpentine administration results in markedly increased serum leptin levels despite the fact that these mice decrease their food intake. IL-1ß is essential for leptin induction during inflammation because neither LPS nor turpentine increases leptin levels in IL-1ß0/0 mice while leptin is normally induced in IL-60/0 mice (Faggioni et al. 1998). However, data addressing changes in thyroid hormone-related gene expression in pituitary and hypothalamus are sparse.

The aims of the present study were to (1) evaluate pituitary and hypothalamic thyroid hormone metabolism during chronic inflammation and (2) differentiate between the effects of chronic inflammation per se and the effects of restricted food intake as a result of illness on pituitary and hypothalamic thyroid hormone metabolism. Thyroid hormone metabolism was evaluated by determining hypothalamic TRH, D2, D3 and TRß1 mRNA expression and pituitary TSHß and D2 mRNA expression in relation to serum T4, T3 and reverse T3 (rT3) levels.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Animals

Female C57Bl6 mice (Harlan Spraque–Dawley, Horst, The Netherlands) weighing approximately 20 g were used at 6–12 weeks of age. The mice were kept in 12 h light:12 h darkness cycles (light on from 0700 to 1900 h), in a temperature-controlled room (22 °C) and food and water were available ad libitum. Aweek before and during the experiment, the mice were housed in groups according to the experimental set-up. Local chronic inflammation was induced by a s.c. injection of 100 µl steam-distilled turpentine in each hind limb. Control mice received saline in each hind limb. Due to the diurnal variation of thyroid hormone-related genes, the experiments were performed using the same time schedule starting at 0900 h (t = 0).

We performed two experiments. In the first experiment, we compared mice with chronic inflammation with control mice who received saline and food ad libitum. In the second experiment, pair-fed control mice were used as controls because food deprivation as a result of illness by itself affects thyroid hormone metabolism. At various time points after turpentine injection (t = 0, 8, 24, 48 and 120 h), four to five mice per group were anaesthetised with isoflurane, blood was taken by cardiac puncture and then mice were killed by cervical dislocation. Serum was stored at –20 °C until analysed. The pituitary and hypothalamus (defined rostrally by the optic chiasm, caudally by the mamillary bodies, laterally by the optic tract and dorsally by the apex of the third ventricle) were isolated and stored immediately in liquid nitrogen. Based on anatomical landmarks (the apex of the third ventricle; Franklin 1997), both paraventricular nuclei, adjoining the third ventricle were obtained by punching the bilateral PVN region with a hollow needle (diameter 1100 µm). These samples may have included (part of) the dorsomedial nucleus (DMN). The same instrument was used to obtain the arcuate nucleus/median eminence region. The study was approved by the local animal welfare committee.

Serum determinations

Serum T3, T4 and rT3 levels were measured with in-house RIAs (Wiersinga & Chopra 1982). To prevent interassay variation, all samples of one experiment were measured within the same assay.

RNA isolation and RT-PCR

mRNA was isolated from whole hypothalamus, PVN and pituitary using the Magna Pure apparatus and the Magna Pure LC mRNA isolation kit II (tissue; Roche Biochemicals) according to the manufacturer’s protocol, and cDNA synthesis was performed with the First Strand cDNA synthesis kit for RT-PCR (AMV; Roche Molecular Biochemicals). In order to check whether the isolated cDNA contains genomic DNA, an RT control reaction was performed after each RNA isolation. Published primer pairs were used to amplify hypoxanthine phosphoribosyl transferase (HPRT, a housekeeping gene; Sweet et al. 2001). We designed primer pairs for IL-1ß (oligo-spanning), D2, D3 (oligo-spanning), TRß1, TSHß and preproTRH (IL-1ß forward: TTGACGGACCCCAAAAGAT and reverse: GAAGCTGGATGCTCTCATCTG; D2 forward: GATGCTCCCAATTCC AGTGT and reverse: AGTGAAAGGTGGTCAGGTGG; D3 forward: CTACGTCATCCAGAGTGGCA and reverse: CTGTTCATCATAGCGCTCCA; TRß1 forward: CACCTGGATCCTGACGATGT and reverse: ACAGGTGATGCAGCG ATAGT; TSHß forward: TCAACACCACCATCTGTGCT and reverse: TTGCCACACTTGCAGCTTAC; pre-proTRH forward: TCGTGCTAACTGGTATCCCC and reverse: CCCAAATCTCCCCTCTCTTC; Boelen et al. 2004). Real-time PCR was performed for quantitation of the above-mentioned mRNAs. cDNA standards for the different mRNAs were prepared from RNA of murine liver, pituitary or hypothalamus. For each mRNA assayed, a standard curve was generated using tenfold serial dilutions of this target standard PCR product and the same primers used to amplify the cDNA. For each gene, the standard protocol was optimised by varying MgCl2 concentrations. PCR were set up with cDNA, MgCl2 (25 mM), SybrGreenI (Roche Molecular Biochemicals), forward and reverse primers and H2O. The reactions were then cycled in the LightCycler (Roche Molecular Biochemicals) as described previously (Boelen et al. 2004). The LightCycler software generated a standard curve (measurements taken during the exponential phase of the amplification) which enabled the amount of each mRNA in each test sample to be determined. All results were corrected as to their mRNA content using HPRT mRNA. Relative expression was presented by arbitrary units, the magnitude depends on the amount of tissue and cDNA dilution used and could be different for each tissue. Samples were individually checked for their PCR efficiency (Ramakers et al. 2003). The median of the efficiency was calculated for each assay and samples with >0.05 difference of the efficiency median value were not taken into account.

Statistics

Data were normally distributed (Shapiro–Wilk test) and presented as the mean ± S.E.M. Variation between turpentine-treated mice and (pair) fed control mice, was evaluated by ANOVA with two grouping factors (time and treatment). P values in the figures represent the significant effect of treatment. In case of time-related changes in the control group, times x treatment (interaction) values are also given. ANOVA was followed by Tukey’s test for pair-wise comparisons (symbols in the figures represent the pair-wise P values.) In case of unequal variances, data were rank transformed prior to ANOVA. All analyses were carried out in SPSS 11.5.1, (SPSS Inc., Chicago, IL, USA). P values < 0.05 were considered statistically significant.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
Effect of chronic inflammation on serum thyroid hormone levels

Turpentine administration causes a sterile abscess at the site of injection (hind limb), which results in serious discomfort. Serum T3, T4 and rT3 levels were significantly decreased 24, 48 and 120 h after injection compared with t = 0. Since chronic illness results in diminished food intake, by itself affecting thyroid hormone metabolism, we also used pair fed mice as controls. Serum T3 levels were similar in chronic inflamed mice compared with pair fed controls, while serum T4 and rT3 levels were significantly lower during chronic inflammation relative to pair fed controls (ANOVA, P < 0.01). The T3/rT3 ratio was significantly higher in turpentine-treated animals compared with pair-fed control mice (ANOVA, P < 0.001) (Fig. 1Go).


Figure 1
View larger version (15K):
[in this window]
[in a new window]

  		Figure 1 Serum levels of T3, T4 and rT3 and T3/rT3 ratio of mice after turpentine-induced chronic inflammation (•-•) compared with saline-treated, pair fed control mice ({circ}-{circ}). Mean values ± S.E.M. (n = 5) are depicted; P values indicate treatment difference between groups by ANOVA and statistical difference between groups at a single time point is indicated by symbols; *P < 0.01. NS, not significant.

 
Effect of chronic inflammation on hypothalamic and pituitary thyroid hormone metabolism

mRNA expression of IL-1ß and several thyroid hormone metabolism-related genes was measured in the hypothalamus and pituitary of mice with chronic inflammation compared with overall ad libitum fed control mice. The results are presented in Fig. 2Go. Turpentine administration resulted in a significant increase in IL-1ß mRNA expression in the whole hypothalamus as well as an increase in D2 mRNA expression shortly after turpentine administration (t = 8 h, P < 0.05). Hypothalamic D3 mRNA expression was not different in mice with chronic inflammation compared with fed control mice (Fig. 2Go). PreproTRH and TRß1 mRNA expression in the whole hypothalamus did not change after turpentine administration (data not shown). Pituitary IL-1ß mRNA expression was significantly increased 120 h after turpentine administration (P < 0.01) compared with fed control mice but was not significantly different during the whole time period (P < 0.1). Pituitary TSHß mRNA expression was different in infected mice compared with fed mice (ANOVA, Pinteraction < 0.01) with significantly decreased TSHß mRNA expression 48 h after turpentine administration and significantly higher TSHß mRNA at 120 h after turpentine administration (Fig. 2Go).


Figure 2
View larger version (15K):
[in this window]
[in a new window]

  		Figure 2 Relative expression of hypothalamic IL-1ß, D2 and D3 mRNA (upper panel) and pituitary IL-1ß, D2 and TSHß mRNA expression (lower panel) of mice after turpentine-induced chronic inflammation (•-•) compared with saline-treated control mice who received food ad libitum ({square}-{square}). Mean values of expression relative to HPRT ± S.E.M. (n = 4) are depicted; P values indicate treatment difference between groups by ANOVA, Pi value indicates significant interaction between time and treatment and statistical difference between groups at a single time point is indicated by symbols: *P < 0.05 and {dagger}P < 0.01. NS, not significant.

 
Effect of chronic inflammation on hypothalamic and pituitary thyroid hormone metabolism compared with food restriction

In order to differentiate between the effects of the inflammatory response by itself and illness-induced decreased food intake on central thyroid hormone metabolism, chronic inflammation was compared with pair fed controls. It is known that TRH mRNA expression of neurons located in the hypothalamic PVN is markedly decreased by restricted food intake and starvation. We therefore measured IL-1ß, preproTRH, D2, D3 and TRß1mRNA expression in this nucleus. D2 mRNA expression was also measured in the arcuate nucleus/median eminence region (ARC). ANOVA revealed significantly higher IL-1ß mRNA expression (P < 0.01) and lower preproTRH mRNA expression in the PVN (P < 0.05) after turpentine administration compared with pair fed controls (Fig. 3Go). IL-1ß mRNA expression in the PVN represents a biphasic response; in the beginning increased expression due to turpentine administration and after 120 h re-increased expression due to a developing systemic acute phase response. D2 and TRß1 mRNA expression after turpentine administration and restricted food intake (pair fed controls) did not change compared with basal levels at t = 0 (data not shown), while D3 mRNA expression in the PVN during chronic inflammation was marginally lower compared with pair fed controls (P = 0.056) especially at 48 h (P < 0.05). D2 mRNA expression in the ARC did not increase significantly during chronic inflammation even though a trend could be found (P = 0.15; Fig. 3Go). Pituitary IL-1ß mRNA expression was increased 120 h after turpentine administration compared with pair fed controls (Fig. 4Go). Pituitary D2 expression was similar in chronically inflamed and pair fed control mice. The timecourse of changes in pituitary TSHß mRNA expression during the observed 120 h was different in infected mice compared with pair fed mice (ANOVA, Pinteraction < 0.01) with significantly decreased TSHß mRNA expression 24 h after turpentine administration and significantly lower TSHß mRNA in pair fed controls at t = 48 h.


Figure 3
View larger version (18K):
[in this window]
[in a new window]

  		Figure 3 Relative expression of IL-1ß, preproTRH and D3 RNA expression in the PVN and D2 mRNA in the ARC of mice after turpentine-induced chronic inflammation (•-•) compared with saline-treated, pair fed control mice ({circ}-{circ}). Mean values of expression relative to HPRT ± S.E.M. (n = 5) are depicted; P values indicate treatment difference between groups by ANOVA and statistical difference between groups at a single time point is indicated by symbols: *P < 0.05 and {dagger}P < 0.01. NS, not significant.

 

Figure 4
View larger version (8K):
[in this window]
[in a new window]

  		Figure 4 Relative expression of pituitary IL-1ß, D2 and TSHß mRNA expression of mice after turpentine-induced chronic inflammation (•-•) compared with saline-treated, pair fed control mice ({circ}-{circ}). Mean values of expression relative to HPRT ± S.E.M. (n = 5) are depicted; P value indicates treatment difference between groups by ANOVA, Pi value indicates significant interaction between time and treatment and statistical difference between groups at a single time point is indicated by symbols: *P < 0.05 and {dagger}P < 0.01. NS, not significant.

 

   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
It is known that profound alterations occur in the central part of the hypothalamic-pituitary-thyroid (HPT)-axis during illness. We and other researchers have shown that acute, systemic illness induced by bacterial endotoxin (LPS) results in downregulation of pituitary thyroid hormone metabolism and an increase in hypothalamic D2 mRNA expression (Boelen et al. 2004) and activity (Fekete et al. 2004) in rodents, while TRH expression is downregulated in direct relation with pre-mortem serum TSH in patients with nonthyroidal illness (Fliers et al. 1997). Starvation on the other hand also results in altered thyroid hormone metabolism in both hypothalamus and pituitary, with decreased TRH expression in the PVN in association with a modest increase in hypothalamic D2 activity (Diano et al. 1998). Both pituitary TSHß and D2 mRNA expression decrease during starvation (Boelen et al. 2006). While the time course of acute illness is too short to show influence of restricted food intake on the observed alterations, the effects of restricted food intake as a result of illness during a longer period may influence central thyroid hormone metabolism We therefore studied pituitary and hypothalamic thyroid hormone metabolism during chronic inflammation in mice differentiating between the effects of restricted food intake and chronic inflammation on pituitary and hypothalamic thyroid hormone metabolism in relation to serum thyroid hormone levels.

A turpentine-induced abscess is a relatively mild model of chronic inflammation with serial activation of specific cytokines resulting in a characteristic acute phase response (Leon 2002). We found a small but significant increase in hypothalamic IL-1ß in association with a rapid increase in hypothalamic D2 mRNA expression. This is in agreement with earlier observations in acute illness (Boelen et al. 2004). In the present study, we did not observe illness-induced alterations in TRH mRNA expression in whole hypothalamus. However, in punched tissue samples containing the PVN region, we observed significant decreased preproTRH mRNA expression after turpentine administration compared with pair fed controls, which was associated with a significant decrease in D3 mRNA expression 48 h after turpentine administration. Increased IL-1ß mRNA expression was more pronounced in this specific region compared with the whole hypothalamus indicating the presence of IL-1ß producing cells in this area. Furthermore, D2 mRNA expression in punched tissue samples containing the arcuate nucleus/median eminence region tended to increase 48 h after turpentine administration (also compared with pair fed controls). D2 mRNA expression did not increase in pair fed animals compared with basal levels at time point 0 indicating that restricted food intake per se did not influence hypothalamic D2 expression in our experimental model. Although we cannot rule out the presence of adjacent nuclei (the DMN, which contains also TRH-expressing neurons) in the PVN punches, it might be plausible that only TRH-expressing hypophysiotropic neurons were affected, since pituitary TSHß mRNA expression and serum thyroid hormone levels were also decreased.

Increased D3 expression during hyperthyroidism and undetectable D3 expression during hypothyroidism have been reported in rat CNS, but hypothalamic D3 expression was of moderate magnitude (Tu et al. 1999). Alkemade et al.(2005) recently showed D3 immunoreactivity in neurons of selective nuclei of the human hypothalamus, perhaps explaining the difference in D3 expression in the present study between whole hypothalamus and punched tissue samples containing PVN more selectively. D3 expression in the human hypothalamus showed a strong overlap with TR expression suggesting that D3 is expressed in T3-responsive neurons. Our results suggest that during chronic illness, T3 bioavailability in the PVN and mediobasal hypothalamus is relatively increased by a downregulation of D3 activity in the PVN and an upregulation of D2 activity in the ARC. This may act, in turn, to decrease preproTRH mRNA in PVN neurons, thereby contributing to persistent low serum concentrations of thyroid hormone. This putative adaptation mechanism was not observed during restricted food intake.

Pituitary thyroid hormone metabolism was partly affected during chronic illness: D2 mRNA expression did not change while TSHß mRNA expression decreased slightly in the beginning during chronic inflammation and ends up higher 120 h after turpentine administration compared with fed controls. The use of pair fed controls showed that this decrease was not solely due to diminished food intake. The TSHß mRNA decrease in pair fed controls was observed after 48 h while after 24 h TSHß mRNA was decreased in the inflamed animals despite the same amount of ingested food. This indicates that food-related signals can be overridden by inflammatory mediators. A possible candidate may be leptin since turpentine administration has been shown to result in a significant increase in serum leptin levels despite decreased food intake (Faggioni et al. 1998). Furthermore, other hypothalamic or pituitary neuropeptides induced during the inflammatory response and specific cytokines could play a role despite the fact that we did not find a predominant IL-1ß response in the pituitary.

The observed decrease in serum T3 levels during chronic inflammation could be ascribed to diminished food intake during the first days of illness, in contrast to the decrease in serum T4 and rT3. It is known that liver D1 is unaffected by turpentine-induced chronic illness which may explain similar serum T3 levels, but additional peripheral deiodinases may be involved. It is tempting to speculate about the role of muscle D2 as it has been shown that muscle D2 is probably the major source of circulating T3 in humans (Maia et al. 2005). This seems, however, less likely in rodents, since Wagner et al.(2003) showed that D2 mRNA expression can be detected in a variety of mouse tissues but not in skeletal muscle, although a recent paper showed that the majority of iodide generated by D1 was not derived from T4 (Schneider et al. 2006). Furthermore, a study of Streckfuss et al.(2005) showed that serum thyroid hormone levels were not different in mice lacking hepatic selenoenzyme expression compared with controls. The early decrease in pituitary TSHß mRNA expression could explain the more severe decrease in serum T4 levels during chronic inflammation. The induction of enzymes other than deiodinases during illness could also play a role in the observed differences in serum T4 and rT3 levels during chronic inflammation compared with pair fed controls. Sulphation of several iodothyronines by sulphotransferases (SULT) is an important pathway in the metabolism of thyroid hormones by, amongst others, affecting deiodination of T4 and T3 by D1. Sulphation of T4 (T4S) and rT3 (rT3S) facilitates inner ring deiodination, while sulphation of T4 impairs outer ring deiodination suggesting that altered sulphotransferases activity affects thyroid hormone levels by itself. However, Peeters et al. (2005a) reported increased T4S levels in critically ill patients but attributed this to decreased liver D1 activity and not to increased SULT1 activity. Furthermore, it has been shown in mice that one member of the SULT2 family (SULT2A1) decreased in liver during the acute-phase response (Kim et al. 2004). These results in combination with the unaltered liver D1 activity in our mouse model (Boelen et al. 2005) did not suggest a prominent role of sulphotransferases in lowering serum T4 and rT3 levels during chronic inflammation. The T3/rT3 ratio was increased during chronic inflammation due to more severely decreased rT3 levels compared with pair fed controls, which is in contrast with results obtained in humans. Peeters et al. (2005b) have shown that the T3/rT3 ratio, a prognostic marker of survival in critically ill patients reflecting alterations in peripheral thyroid hormone metabolism, was lower in nonsurvivors than in survivors. In rodents, however, the kinetics of rT3 are opposite, since Burgi et al.(1986) have already shown in 1986 that serum rT3 increases during fasting but not so during bacterial infection. We observed unchanged serum rT3 levels in pair fed controls, while inflammation resulted in decreased rT3 levels.

In summary, chronic inflammation induces an early increase of hypothalamic D2 mRNA expression potentially resulting in locally increased tissue T3 concentrations. This, in turn, might inhibit preproTRH mRNA expression in hypophysiotropic neurons in the PVN. Proinflammatory cytokines might be involved in the observed D2 mRNA increase as it has been shown that the D2 promoter region contains multiple nuclear factor-kappa B (NF-kB)-binding sites (Zeold et al. 2006). In addition to the early increase in total hypothalamic D2 expression, D3 mRNA expression in the PVN was decreased and D2 mRNA expression seemed to increase in the ARC 48 h after turpentine administration. We are aware of the fact that we did not measure D2 and D3 activity levels in our study, although previous studies have shown that pituitary and hypothalamic D2 mRNA expression during illness correlates well with D2 activity (Boelen et al. 2004, Fekete et al. 2004). Furthermore, the sample size of our experiments in combination with punching hypothalamic regions could be the reason for not reaching statistical significance but we are confident that the results we obtained reflect thyroid hormone metabolism during chronic inflammation. The major function of D2 and D3 in the brain is to regulate local bioavailability of T3 (Lechan & Fekete 2005) and both increased D2 expression and decreased D3 expression may be expected to result in locally increased T3 tissue concentrations. The mechanism involved in hypothalamic D3 mRNA inhibition is unknown at present. D3 mRNA expression may be induced by several growth factors (Huang et al. 2005) and cytokine-related pathways (Pallud et al. 1999). Locally produced glucocorticoids as a result of inflammation might represent an alternative factor capable of downregulating hypothalamic D3 mRNA expression as it is known that IL-1ß activates the central part of the hypothalamic-pituitary-adrenal (HPA)-axis (Turnbull et al. 2003). Finally, diminished food intake as a result of illness in our chronic inflammation model does not explain the illness-induced alterations in hypothalamic D2 and D3 mRNA expression.


   Acknowledgements
 
We would like to thank J Daalhuisen (Department of Experimental Internal Medicine), M Platvoet-ter Schiphorst and A Alkemade (Department of Endocrinology and Metabolism) for expert biotechnical assistance, and the staff of the Laboratory of Endocrinology and Metabolism for measuring thyroid hormones. We also like to thank Dr M Tanck (Department of Clinical Epidemiology) for his advice on the statistical analyses. We are grateful to Dr C van Eden (National Institute of Brain Research, Amsterdam) for his assistance with punching the PVN. The authors declare that there is no conflict of interest that would prejudice the impartiality of this scientific work.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E & Flier JS 1996 Role of leptin in the neuroendocrine response to fasting. Nature 382 250–252.[CrossRef][Medline]

Alkemade A, Friesema EC, Unmehopa UA, Fabriek BO, Kuiper GG, Leonard JL, Wiersinga WM, Swaab DF, Visser TJ & Fliers E 2005 Neuroanatomical pathways for thyroid hormone feedback in the human hypothalamus. Journal of Clinical Endocrinology and Metabolism 90 4322–4334.[Abstract/Free Full Text]

Boelen A, Kwakkel J, Thijssen-Timmer DC, Alkemade A, Fliers E & Wiersinga WM 2004 Simultaneous changes in central and peripheral components of the hypothalamus–pituitary–thyroid axis in lipopolysaccharide-induced acute illness in mice. Journal of Endocrinology 182 315–323.[Abstract]

Boelen A, Kwakkel J, Alkemade A, Renckens R, Kaptein E, Kuiper G, Wiersinga WM & Visser TJ 2005 Induction of type 3 deiodinase activity in inflammatory cells of mice with chronic local inflammation. Endocrinology 146 5128–5134.[Abstract/Free Full Text]

Boelen A, Kwakkel J, Vos XG, Wiersinga WM & Fliers E 2006 Differential effects of leptin and refeeding on the fasting-induced decrease of pituitary type 2 deiodinase and thyroid hormone receptor ß2 mRNA expression in mice. Journal of Endocrinology 190 537–544.[Abstract/Free Full Text]

Burgi U, Feller C & Gerber AU 1986 Effects of an acute bacterial infection on serum thyroid hormones and nuclear triiodothyronine receptors in mice. Endocrinology 119 515–521.[Abstract/Free Full Text]

Chopra IJ, Huang TS, Boado R, Solomon DH & Chua Teco GN 1987 Evidence against benefit from replacement doses of thyroid hormones in nonthyroidal illness (NTI): studies using turpentine oil-injected rat. Journal of Endocrinological Investigations 10 559–564.

Coppola A, Meli R & Diano S 2005 Inverse shift in circulating corticosterone and leptin levels elevates hypothalamic deiodinase type 2 in fasted rats. Endocrinology 146 2827–2833.[Abstract/Free Full Text]

Diano S, Naftolin F, Goglia F & Horvath TL 1998 Fasting-induced increase in type II iodothyronine deiodinase activity and messenger ribonucleic acid levels is not reversed by thyroxine in the rat hypothalamus. Endocrinology 139 2879–2884.[Abstract/Free Full Text]

Faggioni R, Fantuzzi G, Fuller J, Dinarello CA, Feingold KR & Grunfeld C 1998 IL-1 beta mediates leptin induction during inflammation. American Journal of Physiology 274 R204–R208.

Fekete C, Gereben B, Doleschall M, Harney JW, Dora JM, Bianco AC, Sarkar S, Liposits Z, Rand W, Emerson C et al. 2004 Lipopolysaccharide induces type 2 iodothyronine deiodinase in the mediobasal hypothalamus: implications for the nonthyroidal illness syndrome. Endocrinology 145 1649–1655.[Abstract/Free Full Text]

Fliers E, Guldenaar SE, Wiersinga WM & Swaab DF 1997 Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness. Journal of Clinical Endocrinology and Metabolism 82 4032–4036.[Abstract/Free Full Text]

Franklin KBJ 1997 The Mouse Brain in Stereotaxic Coordinates., San Diego: Academic Press.

Huang SA, Mulcahey MA, Crescenzi A, Chung M, Kim BW, Barnes C, Kuijt W, Turano H, Harney J & Larsen PR 2005 Transforming growth factor-beta promotes inactivation of extracellular thyroid hormones via transcriptional stimulation of type 3 iodothyronine deiodinase. Molecular Endocrinology 19 3126–3136.[Abstract/Free Full Text]

Kim MS, Shigenaga J, Moser A, Grunfeld C & Feingold KR 2004 Suppression of DHEA sulfotransferase (Sult2A1) during the acute-phase response. American Journal of Physiology 287 E731–E738.

Koenig RJ 2005 Regulation of type 1 iodothyronine deiodinase in health and disease. Thyroid 15 835–840.[CrossRef][Web of Science][Medline]

Lechan RM & Fekete C 2005 Role of thyroid hormone deiodination in the hypothalamus. Thyroid 15 883–897.[CrossRef][Web of Science][Medline]

Legradi G, Emerson CH, Ahima RS, Flier JS & Lechan RM 1997 Leptin prevents fasting-induced suppression of prothyrotropin-releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus. Endocrinology 138 2569–2576.[Abstract/Free Full Text]

Leon LR 2002 Invited review: Cytokine regulation of fever: studies using gene knockout mice. Journal of Applied Physiology 92 2648–2655.[Abstract/Free Full Text]

Maia AL, Kim BW, Huang SA, Harney JW & Larsen PR 2005 Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans. Journal of Clinical Investigations 115 2524–2533.[CrossRef][Web of Science][Medline]

Pallud S, Ramauge M, Gavaret JM, Lennon AM, Munsch N, St Germain DL, Pierre M & Courtin F 1999 Regulation of type 3 iodothyronine deiodinase expression in cultured rat astrocytes: role of the Erk cascade. Endocrinology 140 2917–2923.[Abstract/Free Full Text]

Papanicolaou DA 2000 Euthyroid sick syndrome and the role of cytokines. Reviews of Endocrinological and Metabolic Disorders 1 43–48.

Peeters RP, Wouters PJ, Van Toor H, Kaptein E, Visser TJ & Van den Berghe G 2005a Serum 3,3' ,5'-triiodothyronine (rT3) and 3,5,3'-triiodothyronine/rT3 are prognostic markers in critically ill patients and are associated with postmortem tissue deiodinase activities. Journal of Clinical Endocrinology and Metabolism 90 4559–4565.[Abstract/Free Full Text]

Peeters RP, Kester MH, Wouters PJ, Kaptein E, Van Toor H, Visser TJ & Van den Berghe G 2005b Increased thyroxine sulfate levels in critically ill patients as a result of a decreased hepatic type I deiodinase activity. Journal of Clinical Endocrinology and Metabolism 90 6460–6465.[Abstract/Free Full Text]

Ramakers C, Ruijter JM, Deprez RH & Moorman AF 2003 Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neuroscience Letters 339 62–66.[CrossRef][Web of Science][Medline]

Schneider MJ, Fiering SN, Thai B, Wu SY, Parlow AF, St Germain DL & Galton VA 2006 Targeted disruption of the type 1 selenodeiodinase gene (Dio1) results in marked changes in thyroid hormone economy in mice. Endocrinology 147 580–589.[CrossRef][Web of Science][Medline]

Streckfuss F, Hamann I, Schomburg L, Michaelis M, Sapin R, Klein MO, Kohrle J & Schweizer U 2005 Hepatic deiodinase activity is dispensable for the maintenance of normal circulating thyroid hormone levels in mice. Biochemical and Biophysical Research Communications 337 739–745.[CrossRef][Web of Science][Medline]

Sweet MJ, Leung BP, Kang D, Sogaard M, Schulz K, Trajkovic V, Campbell CC, Xu D & Liew FY 2001 A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression. Journal of Immunology 166 6633–6639.[Abstract/Free Full Text]

Tu HM, Legradi G, Bartha T, Salvatore D, Lechan RM & Larsen PR 1999 Regional expression of the type 3 iodothyronine deiodinase messenger ribonucleic acid in the rat central nervous system and its regulation by thyroid hormone. Endocrinology 140 784–790.[Abstract/Free Full Text]

Turnbull AV, Prehar S, Kennedy AR, Little RA & Hopkins SJ 2003 Interleukin-6 is an afferent signal of the hypothalamus–pituitary–adrenal axis during local inflammation in mice. Endocrinology 144 1894–1906.[Abstract/Free Full Text]

Wagner MS, Morimoto R, Dora JM, Benneman A, Pavan R & Maia AL 2003 Hypothyroidism induces type 2 iodothyronine deiodinase expression in mouse heart and testis. Journal of Molecular Endocrinology 31 541–550.[Abstract]

Wiersinga WM & Chopra IJ 1982 Radioimmunoassay of thyroxine (T4), 3,5,3'-triiodothyronine (T3), 3,3' ,5'-triiodothyronine (reverse T3, rT3), and 3,3'-diiodothyronine (T2). Methods of Enzymology 84 272–303.

Woloski BM & Jamieson JC 1987 Rat corticotropin, insulin and thyroid hormone levels during the acute phase response to inflammation. Comparative Biochemical and Physiology A86 15–19.

Zeold A, Doleschall M, Haffner MC, Capelo LP, Menyhert J, Liposits Z, da Silva WS, Bianco AC, Kacskovics I, Fekete C et al. 2006 Characterization of the nuclear factor-kappa B responsiveness of the human dio2 gene. Endocrinology 147 4419–4429.[Abstract/Free Full Text]

Received in final form 22 September 2006
Accepted 26 September 2006
Made available online as an Accepted Preprint 2 October 2006




This article has been cited by other articles:


Home page
 J Mol EndocrinolHome page
L. Calza, M. Fernandez, and L. Giardino
Cellular approaches to central nervous system remyelination stimulation: thyroid hormone to promote myelin repair via endogenous stem and precursor cells
J. Mol. Endocrinol., January 1, 2010; 44(1): 13 - 23.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
B. Gereben, A. M. Zavacki, S. Ribich, B. W. Kim, S. A. Huang, W. S. Simonides, A. Zeold, and A. C. Bianco
Cellular and Molecular Basis of Deiodinase-Regulated Thyroid Hormone Signaling
Endocr. Rev., December 1, 2008; 29(7): 898 - 938.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boelen, A
Right arrow Articles by Fliers, E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boelen, A
Right arrow Articles by Fliers, E

HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS